Johnson & Johnson MedTech Neurovascular Worldwide President Mark Dickinson is leaving J&J after a 26-year career.

Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

Paradromics announced today that it selected investigators for an upcoming clinical study of its brain-computer interface ...

Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...

Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

Among major medtech stocks, Intuitive Surgical, Boston Scientific and Stryker have had an especially rough week.

Helius Medical Technologies (Nasdaq:HSDT) announced today that it established Revelation Neuro, a brain-computer interface ...

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding ...

Olympus announced that it launched its first AI-powered clinical decision tool in collaboration with software company Ziosoft ...